[HTML][HTML] Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions–a narrative review

H Huber, A Schieren, JJ Holst, MC Simon - The American Journal of …, 2024 - Elsevier
Abstract Glucagon-like peptide 1 (GLP-1), a gastrointestinal peptide and central mediator of
glucose metabolism, is secreted by L cells in the intestine in response to food intake …

Microbiome‐modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta‐analysis, and meta‐regression of clinical trials

R Kaul, P Paul, M Harfouche, R Saliba… - Diabetes/Metabolism …, 2024 - Wiley Online Library
Abstract Aims Type 2 Diabetes is intrinsically linked to cardiovascular disease (CVD) via
diabetic dyslipidemia, both of which remain global health concerns with annually increasing …

Gut microbiome and polycystic ovary syndrome: interplay of Associated Microbial-Metabolite pathways and therapeutic strategies

A Babu, V Devi Rajeswari, V Ganesh, S Das… - Reproductive …, 2024 - Springer
Polycystic ovary syndrome (PCOS) is a multifaceted disease with an intricate etiology
affecting reproductive-aged women. Despite attempts to unravel the pathophysiology, the …

Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications

S Facchin, L Bertin, E Bonazzi, G Lorenzon… - Life, 2024 - mdpi.com
The gastrointestinal tract is home to trillions of diverse microorganisms collectively known as
the gut microbiota, which play a pivotal role in breaking down undigested foods, such as …

Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches

LM Williams, S Cao - Pharmacology & Therapeutics, 2024 - Elsevier
Microbial metabolites have emerged as key players in the interplay between diet, the gut
microbiome, and host health. Two major classes, short-chain fatty acids (SCFAs) and …

The mechanisms in the gut microbiota regulation and type 2 diabetes therapeutic activity of resistant starches

X Li, R Chen, J Wen, R Ji, X Chen, Y Cao, Y Yu… - International Journal of …, 2024 - Elsevier
Resistant starch (RS) can potentially prevent type 2 diabetes through the modulation of
intestinal microbiota and microbial metabolites. Currently, it has been wildly noted that …

[HTML][HTML] HP inulin-MCT dietary fiber improves lipid metabolism and prevents non-alcoholic steatohepatitis in obese mice

Y Tjahjono, K Foe, YR Wilianto, WC Khudrati… - Journal of Functional …, 2024 - Elsevier
Introduction Regular intake of dietary fiber (DF) can counteract the negative impacts of
obesity on physical health and chronic disease risk. DF mitigates obesity by promoting …

Assessing the therapeutic potential of long-chain isomaltooligosaccharides in diabetic and hyperlipidemic rats

O Reamtong, R Waeonukul, P Prangthip - Diabetology & Metabolic …, 2024 - Springer
Background The global rise in diabetes prevalence necessitates effective treatments. Rats,
mimicking physiological changes seen in Type 2 diabetes, serve as valuable models for …

No benefit of soluble fiber on liver function: A systematic review and meta-analysis of controlled trials

A Ghavami, S Talebi, H Barghchi… - … Journal for Vitamin …, 2024 - econtent.hogrefe.com
Background: To conduct a systematic review and dose-response meta-analysis of current
findings from randomized controlled trials (RCTs) on the effect of soluble fiber …

The Interplay of Gut Microbiome in Health and Diseases

T Mishra, B Mallik, M Kesheri, S Kanchan - Microbial Omics in …, 2024 - Springer
The gut microbiome, a complex ecosystem of trillions of microorganisms in the human
gastrointestinal tract, has emerged as a central player in maintaining host health and …